Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Human papillomavirus (HPV) type-specific strategies play a key role in the prevention of cervical intraepithelial neoplasia (CIN), but evidence on the HPV type-specific prevalence in CIN is limited. WHAT IS ADDED BY THIS REPORT? This multicentric study estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Heling, Chen, Weihong, Zhang, Xiaosong, Bi, Hui, Zhao, Yun, Fang, Liwen, Cong, Shu, Tan, Feng, Wang, Linhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889231/
https://www.ncbi.nlm.nih.gov/pubmed/36751369
http://dx.doi.org/10.46234/ccdcw2022.218
Descripción
Sumario:WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Human papillomavirus (HPV) type-specific strategies play a key role in the prevention of cervical intraepithelial neoplasia (CIN), but evidence on the HPV type-specific prevalence in CIN is limited. WHAT IS ADDED BY THIS REPORT? This multicentric study estimates the prevalence of high-risk HPV types in CIN cases and the associations of HPV infection patterns with high-grade CIN in China in 2017–2018. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? Population-based prevention strategies should give preference to HPV-16 and 18, and strategies for non-16/18 high-risk HPV are essential for the elimination of cervical cancer.

Ejemplares similares